Vemurafenib in patients with BRAFV600 mutation-positive melanoma with symptomatic brain metastases: Final results of an open-label pilot study

Title
Vemurafenib in patients with BRAFV600 mutation-positive melanoma with symptomatic brain metastases: Final results of an open-label pilot study
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF CANCER
Volume 50, Issue 3, Pages 611-621
Publisher
Elsevier BV
Online
2013-11-29
DOI
10.1016/j.ejca.2013.11.002

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started